Remove Blood Clot Remove Innovation Remove Patient Care
article thumbnail

Osso VR Expands Cardiology Training through ACC Collaboration

DAIC

Left Atrial Appendage Occlusion (LAAO) procedures are done to reduce the risk of stroke in patients with atrial fibrillation by sealing off the left atrial appendage, preventing the formation of blood clots. Both Osso VR and the American College of Cardiology are committed to excellence in medical education and patient care.

article thumbnail

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

Mohr-Durdez added, “To help enhance patient care in this field, Volta Medical aims to further integrate its AI solution with EP innovators to help increase compatibility and address the challenges clinicians face in analyzing cardiac electrical signals.” 1 Approximately 33 million patients worldwide are living with AFib.

article thumbnail

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

DAIC

Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a blood clot forms in the vein [2]. It is the third most common cardiovascular disease [2]. Deep venous anatomy and obstructions can present a multitude of complexities and mechanical challenges.

Stents 105
article thumbnail

Comprehending the Dreadful Impacts of COVID-19 on Cardiovascular Treatments

SoftCath

MedicalNewsToday reported that people suffering from Covid-19 infection might develop blood clots in various arteries of their bodies which can cause improper circulation of blood. Apart from blood clotting, in some Covid-19 patients, a higher risk of heart failure and heart attacks has been witnessed by the hospitals.

article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

Staying informed about these cutting-edge developments is critical for providing exceptional patient care. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. The label includes a “black box” warning for CV risk due to blood clots.